Publikationer 2017
-
A CRISPR-Cas9 Generated MDCK Cell Line Expressing Human MDR1 Without Endogenous Canine MDR1 (cABCB1): An Improved Tool for Drug Efflux Studies.
Ingår i Journal of Pharmaceutical Sciences, s. 2909-2913, 2017.
-
Characterization of Solubilizing Nanoaggregates Present in Different Versions of Simulated Intestinal Fluid
Ingår i Journal of Physical Chemistry B, s. 10869-10881, 2017.
DOI för Characterization of Solubilizing Nanoaggregates Present in Different Versions of Simulated Intestinal Fluid Ladda ner fulltext (pdf) av Characterization of Solubilizing Nanoaggregates Present in Different Versions of Simulated Intestinal Fluid
-
Controlled Suspensions Enable Rapid Determinations of Intrinsic Dissolution Rate and Apparent Solubility of Poorly Water-Soluble Compounds
Ingår i Pharmaceutical research, s. 1805-1816, 2017.
DOI för Controlled Suspensions Enable Rapid Determinations of Intrinsic Dissolution Rate and Apparent Solubility of Poorly Water-Soluble Compounds Ladda ner fulltext (pdf) av Controlled Suspensions Enable Rapid Determinations of Intrinsic Dissolution Rate and Apparent Solubility of Poorly Water-Soluble Compounds
-
Enhanced release of poorly water-soluble drugs from synergy between mesoporous magnesium carbonate and polymers
Ingår i International Journal of Pharmaceutics, s. 183-190, 2017.
-
Identification of Triazolothiadiazoles as Potent Inhibitors of the dCTP Pyrophosphatase 1
Ingår i Journal of Medicinal Chemistry, s. 2148-2154, 2017.
DOI för Identification of Triazolothiadiazoles as Potent Inhibitors of the dCTP Pyrophosphatase 1
-
Intracellular drug bioavailability: a new predictor of system dependent drug disposition
Ingår i Scientific Reports, s. 1-12, 2017.
DOI för Intracellular drug bioavailability: a new predictor of system dependent drug disposition Ladda ner fulltext (pdf) av Intracellular drug bioavailability: a new predictor of system dependent drug disposition
-
Investigation of the Intra- and Interlaboratory Reproducibility of a Small Scale Standardized Supersaturation and Precipitation Method
Ingår i Molecular Pharmaceutics, s. 4161-4169, 2017.
-
Mechanism-based selection of stabilization strategy for amorphous formulations: Insights into crystallization pathways
Ingår i Journal of Controlled Release, s. 193-202, 2017.
DOI för Mechanism-based selection of stabilization strategy for amorphous formulations: Insights into crystallization pathways Ladda ner fulltext (pdf) av Mechanism-based selection of stabilization strategy for amorphous formulations: Insights into crystallization pathways
-
Molecular Structuring and Phase Transition of Lipid-Based Formulations upon Water Dispersion: A Coarse-Grained Molecular Dynamics Simulation Approach
Ingår i Molecular Pharmaceutics, s. 4145-4153, 2017.
DOI för Molecular Structuring and Phase Transition of Lipid-Based Formulations upon Water Dispersion: A Coarse-Grained Molecular Dynamics Simulation Approach Ladda ner fulltext (pdf) av Molecular Structuring and Phase Transition of Lipid-Based Formulations upon Water Dispersion: A Coarse-Grained Molecular Dynamics Simulation Approach
-
Piperazin-1-ylpyridazine Derivatives Are a Novel Class of Human dCTP Pyrophosphatase 1 Inhibitors
Ingår i Journal of Medicinal Chemistry, s. 4279-4292, 2017.
-
Prediction of intracellular exposure bridges the gap between target- and cell-based drug discovery
Ingår i Proceedings of the National Academy of Sciences of the United States of America, s. E6231-E6239, 2017.
-
Substrate and method dependent inhibition of three ABC-transporters (MDR1, BCRP, and MRP2)
Ingår i European Journal of Pharmaceutical Sciences, s. 70-76, 2017.
DOI för Substrate and method dependent inhibition of three ABC-transporters (MDR1, BCRP, and MRP2)
-
The Need for Restructuring the Disordered Science of Amorphous Drug Formulations
Ingår i Pharmaceutical Research, s. 1754-1772, 2017.
DOI för The Need for Restructuring the Disordered Science of Amorphous Drug Formulations Ladda ner fulltext (pdf) av The Need for Restructuring the Disordered Science of Amorphous Drug Formulations
-
Variability in Mass Spectrometry-based Quantification of Clinically Relevant Drug Transporters and Drug Metabolizing Enzymes
Ingår i Molecular Pharmaceutics, s. 3142-3151, 2017.
DOI för Variability in Mass Spectrometry-based Quantification of Clinically Relevant Drug Transporters and Drug Metabolizing Enzymes Ladda ner fulltext (pdf) av Variability in Mass Spectrometry-based Quantification of Clinically Relevant Drug Transporters and Drug Metabolizing Enzymes